GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

Summary

This phase II trial is studying how well giving GTI-2040 together with capecitabine works in treating patients with metastatic breast cancer. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. GTI-2040 may help capecitabine kill more tumor cells by making them more sensitive to the drug

Timeline

Start

2003-10

Primary completion

2010-03

Completion

2010-03

Drugs

Indications